Yat Ming Lau

516 total citations
13 papers, 350 citations indexed

About

Yat Ming Lau is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Yat Ming Lau has authored 13 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Rheumatology. Recurrent topics in Yat Ming Lau's work include Lung Cancer Treatments and Mutations (5 papers), Eosinophilic Disorders and Syndromes (2 papers) and Cervical Cancer and HPV Research (2 papers). Yat Ming Lau is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Eosinophilic Disorders and Syndromes (2 papers) and Cervical Cancer and HPV Research (2 papers). Yat Ming Lau collaborates with scholars based in China, Hong Kong and Australia. Yat Ming Lau's co-authors include Enrique Soto‐Pérez‐de‐Celis, Yuan Yuan, Daneng Li, Arti Hurria, Tony Mok, Herbert H. Loong, Paul K.S. Chan, Winnie Yeo, Apple C. M. Yeung and Wendy C. S. Ho and has published in prestigious journals such as PLoS ONE, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Yat Ming Lau

13 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yat Ming Lau China	7	142	118	89	70	55	13	350
S. Luce Belgium	4	146 1.0×	156 1.3×	88 1.0×	113 1.6×	49 0.9×	10	320
Capucine Baldini France	10	184 1.3×	93 0.8×	96 1.1×	41 0.6×	36 0.7×	19	336
S. Zonato Italy	11	181 1.3×	116 1.0×	128 1.4×	90 1.3×	39 0.7×	21	375
Carla Codecà Italy	10	169 1.2×	97 0.8×	112 1.3×	72 1.0×	28 0.5×	19	364
Björn Penninckx United Kingdom	5	160 1.1×	146 1.2×	93 1.0×	82 1.2×	71 1.3×	7	378
Marika Rasschaert Belgium	12	261 1.8×	209 1.8×	109 1.2×	153 2.2×	72 1.3×	32	545
J. Provençal France	5	148 1.0×	169 1.4×	77 0.9×	106 1.5×	44 0.8×	10	366
J.-F. Geay France	6	176 1.2×	169 1.4×	84 0.9×	106 1.5×	44 0.8×	15	479
Edmund Folefac United States	10	133 0.9×	50 0.4×	111 1.2×	49 0.7×	21 0.4×	36	301
W. Chris Taylor United States	6	153 1.1×	195 1.7×	92 1.0×	131 1.9×	57 1.0×	8	338

Countries citing papers authored by Yat Ming Lau

Since Specialization

Citations

This map shows the geographic impact of Yat Ming Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yat Ming Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yat Ming Lau more than expected).

Fields of papers citing papers by Yat Ming Lau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yat Ming Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yat Ming Lau. The network helps show where Yat Ming Lau may publish in the future.

Co-authorship network of co-authors of Yat Ming Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Yat Ming Lau. A scholar is included among the top collaborators of Yat Ming Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yat Ming Lau. Yat Ming Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lee, Kirsty, Herbert H. Loong, Landon L. Chan, et al.. (2024). Brief Report: Risk of Recurrent Interstitial Lung Disease From Osimertinib Versus Erlotinib Rechallenge After Symptomatic Osimertinib-Induced Interstitial Lung Disease. JTO Clinical and Research Reports. 5(4). 100648–100648. 3 indexed citations

Lam, Chun Sing, Rong Hua, Tai Ning Lam, et al.. (2023). Can ChatGPT Provide Quality Information on Integrative Oncology? A Brief Report. Journal of Integrative and Complementary Medicine. 30(2). 196–205. 1 indexed citations

Lee, Kirsty, Herbert H. Loong, Yat Ming Lau, et al.. (2023). P2.09-24 Risk of Recurrent Interstitial Lung Disease (ILD) from EGFR TKI Rechallenge after Osimertinib Induced ILD. Journal of Thoracic Oncology. 18(11). S342–S342. 1 indexed citations

Li, M., Landon L. Chan, Kirsty Lee, et al.. (2023). 1349P Continuing osimertinib in combination with chemotherapy after osimertinib failure reduces CNS progression in patients with EGFR-mutated NSCLC and CNS metastases. Annals of Oncology. 34. S776–S777. 3 indexed citations

Lee, Kirsty, Wanxia Gai, Yat Ming Lau, et al.. (2022). Testing for EGFR Variants in Pleural and Pericardial Effusion Cell-Free DNA in Patients With Non–Small Cell Lung Cancer. JAMA Oncology. 9(2). 261–261. 6 indexed citations

Loong, Herbert H., et al.. (2020). Prevalence and prognostic impact of comorbidities and peripheral blood indices in sarcomas. ESMO Open. 5(6). e001035–e001035. 7 indexed citations

Loong, Herbert H., et al.. (2019). Prevalence and prognostic impact of comorbidities in sarcomas: A population-based study of 3746 patients in Hong Kong. Annals of Oncology. 30. vi88–vi88. 1 indexed citations

Loong, Herbert H., et al.. (2018). Therapeutic Strategies in EGFR Mutant Non-Small Cell Lung Cancer. Current Treatment Options in Oncology. 19(11). 58–58. 36 indexed citations

Soto‐Pérez‐de‐Celis, Enrique, Daneng Li, Yuan Yuan, Yat Ming Lau, & Arti Hurria. (2018). Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer. The Lancet Oncology. 19(6). e305–e316. 251 indexed citations

10.

Lau, Yat Ming, Tak Hong Cheung, Winnie Yeo, et al.. (2015). Prognostic Implication of Human Papillomavirus Types and Species in Cervical Cancer Patients Undergoing Primary Treatment. PLoS ONE. 10(4). e0122557–e0122557. 17 indexed citations

11.

Lau, Yat Ming, et al.. (2014). Trachyonychia in a patient with chronic myeloid leukaemia after imatinib mesylate. Hong Kong Medical Journal. 20(5). 464.e2–464.e2. 6 indexed citations

12.

Yip, Shea Ping, Chi Chung Chan, Chi Shan Kho, et al.. (2014). Genetic association between germline JAK2polymorphisms and myeloproliferative neoplasms in Hong Kong Chinese population: a case–control study. BMC Genetics. 15(1). 147–147. 7 indexed citations

13.

Lau, Yat Ming, et al.. (1998). THE POTENTIAL IMPACT OF BREAST CANCER SCREENING IN HONG KONG. Australian and New Zealand Journal of Surgery. 68(10). 707–711. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact